KRAS and hepatocellular carcinoma: Applying a targeted chemical screening process, a small molecule NSC48160 was identified as an efficacious inhibitor of KRAS target, which regulated ROS production, mitochondrial stress, and the induction of growth arrest ultimately, specifically within HCC cells under the upregulation of the TCA cycle.